DARE 8-K 2026-10-02
Dare Bioscience, Inc. (DARE) 8-K dated 2026-10-02 — accession 0001401914-26-000052.
Dare Bioscience, Inc. (DARE) is a biotechnology company listed on US.
Dare Bioscience, Inc. filed a 8-K on 2026-10-02. Accession 0001401914-26-000052.
This 8-K covers: Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported DARE revenue for 2025-12-31 was $1.0M. Net income was -$13.4M. Revenue was down 63.3% from 2023-12-31 to 2025-12-31. DARE currently screens at market cap $21.2M.
Not investment advice. The DARE SEC hub lists recent forms. The stock page is the research view.